PCI-29732 is a BTK inhibitor. It acts by blocking B cell antigen receptor (BCR)-mediated gene expression in CD20+ B cells.
For research use only. We do not sell to patients.
| Name | PCI-29732 |
|---|---|
| Iupac Chemical Name | 1-Cyclopentyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
| Synonyms | PCI-29732; PCI 29732; PCI29732; |
| Molecular Formula | C22H21N5O |
| Molecular Weight | 371.44 |
| Smile | NC1=C2C(N(C3CCCC3)N=C2C4=CC=C(OC5=CC=CC=C5)C=C4)=NC=N1 |
| InChiKey | GMJUPMONHWAZCP-UHFFFAOYSA-N |
| InChi | InChI=1S/C22H21N5O/c23-21-19-20(26-27(16-6-4-5-7-16)22(19)25-14-24-21)15-10-12-18(13-11-15)28-17-8-2-1-3-9-17/h1-3,8-14,16H,4-7H2,(H2,23,24,25) |
| CAS Number | 330786-25-9 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | >98% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |